(BSCV) Invesco BulletShares 2031 - Ratings and Ratios
Exchange: NASDAQ • Country: USA • Currency: USD • Type: Etf • ISIN: US46138J4296 • Target Maturity
BSCV: Corporate, Bonds, U.S. Dollar, Investment, Grade, Securities
As an exchange-traded fund (ETF), the Invesco BulletShares 2031 Corporate Bond ETF (NASDAQ: BSCV) is designed to track the performance of a specific segment of the corporate bond market. The fund primarily invests in U.S. dollar-denominated investment-grade corporate bonds that are set to mature in 2031. This targeted approach allows investors to gain exposure to a portfolio of bonds with a defined maturity, providing clarity on when principal payments will be returned. The ETFs structure is akin to a bond ladder, where investors hold bonds with staggered maturities, but in this case, the focus is narrowly concentrated on the 2031 maturity.
With assets under management (AUM) of $888.40 million, the fund offers a diversified portfolio of corporate bonds issued by various issuers across different sectors. By holding a range of bonds within the investment-grade category, the ETF aims to mitigate credit risk through diversification. The funds investment strategy is straightforward: it seeks to replicate the performance of its underlying index, which is composed of 2031-maturity bonds. This makes it an attractive option for investors looking for predictable income and the potential return of principal as the bonds approach their maturity dates.
Looking ahead, the Invesco BulletShares 2031 Corporate Bond ETF is positioned to appeal to investors seeking predictable income streams with defined maturity profiles. As the 2031 maturity date approaches, the funds interest rate risk will diminish, making it less sensitive to fluctuations in interest rates. This characteristic can be particularly advantageous in a rising rate environment, where longer-duration bonds tend to underperform. Additionally, as the bonds in the portfolio mature, the fund will likely distribute the principal back to investors, providing a clear endpoint for the investment. This structure aligns well with the financial planning needs of institutions and individuals who require precise cash flows at specific future dates. The funds targeted maturity approach also underscores the importance of matching assets with liabilities, a principle that Aswath Damodaran has often emphasized in his analysis of corporate finance and investment strategies.
Additional Sources for BSCV ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
BSCV ETF Overview
Market Cap in USD | 912m |
Category | Target Maturity |
TER | 0.10% |
IPO / Inception | 2021-09-15 |
BSCV ETF Ratings
Growth 5y | 10.4% |
Fundamental | - |
Dividend | 75.4% |
Rel. Strength Industry | -1.27 |
Analysts | - |
Fair Price Momentum | 15.81 USD |
Fair Price DCF | - |
BSCV Dividends
Dividend Yield 12m | 4.48% |
Yield on Cost 5y | 4.15% |
Annual Growth 5y | 53.19% |
Payout Consistency | 100.0% |
BSCV Growth Ratios
Growth Correlation 3m | 73% |
Growth Correlation 12m | 73.8% |
Growth Correlation 5y | 9.7% |
CAGR 5y | -1.89% |
CAGR/Max DD 5y | -0.08 |
Sharpe Ratio 12m | -0.82 |
Alpha | 0.83 |
Beta | 0.15 |
Volatility | 4.72% |
Current Volume | 441.8k |
Average Volume 20d | 276.4k |
As of March 14, 2025, the stock is trading at USD 16.24 with a total of 441,836 shares traded.
Over the past week, the price has changed by -0.37%, over one month by +1.01%, over three months by +1.16% and over the past year by +5.65%.
Neither. Based on ValueRay Analyses, Invesco BulletShares 2031 is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 10.39 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of BSCV as of March 2025 is 15.81. This means that BSCV is currently overvalued and has a potential downside of -2.65%.
Invesco BulletShares 2031 has no consensus analysts rating.
According to ValueRays Forecast Model, BSCV Invesco BulletShares 2031 will be worth about 17.1 in March 2026. The stock is currently trading at 16.24. This means that the stock has a potential upside of +5.17%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 17.1 | 5.2% |